Paola Grandi

Paola Grandi

Company: CG Oncology

Job title: CSO


Attacking Solid Tumors and Other Cancers in Combination With Immune Checkpoint Inhibitors 9:00 am

• Phase 2 trial data showing cancer-selective oncolytic immunotherapy • Advancement of a fully owned CTLA-4 antibody into the clinic after completion of IND-enabling studies are completedRead more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.